Scientific Advisory Board

To ensure a high quality of research is maintained over the long term, all Max Planck Institutes are subject to regular assessment from independent advisory boards. The board members, experts from leading international research institutions and universities, are selected by the president of the Max Planck Society on the basis of suggestions from the institutes. They are elected to the board for a maximum term of six years.

Our institute's Scientific Advisory Board is currently composed of 21 members:

  • Prof. Dr. Mike Ashfold,
    School of Chemistry, University of Bristol, UK
  • Prof. Dr. Hugo J. Bellen,
    Baylor College of Medicine, Howard Hughes Medical Institute, Houston, USA
  • Prof. Dr. Carmen Birchmeier-Kohler,
    Max-Delbrück-Centrum für Molekulare Medizin, Berlin
  • Prof. Dr. David A. Case,
    BioMaPS Institute and Department of Chemistry & Chemical Biology, Rutgers University, Piscataway, USA
  • Prof. Dr. Susan M. Gasser,
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
  • Prof. Dr. John Griffiths,
    Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
  • Prof. Dr. Ari Helenius,
    Institut für Biochemie, ETH Zürich, Zürich, Switzerland
  • Prof. Dr. Steve A. Kay,
    President, The Scripps Research Institute, La Jolla, California, USA
  • Prof. Dr. Ann McDermott,
    Department of Chemistry, Columbia University, New York, USA
  • Prof. Dr. Jane Mellor,
    Deparment of Biochemistry, University of Oxford, Oxford, UK
  • Prof. Dr. Martha Merrow,
    Institute of Medical Psychology, Ludwig-Maximilians-Universität München, München
  • Prof. Dr. David Nesbitt,
    Department of Chemistry and Biochemistry, University of Colorado at Boulder, Boulder, USA
  • Prof. Dr. José Rizo-Rey,
    Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, USA
  • Prof. Dr. Mark S. P. Sansom,
    Department of Biochemistry, University of Oxford, Oxford, UK
  • Prof. Dr. Thomas U. Schwartz,
    Department of Biology, Massachussetts Institute of Technology, Cambridge, USA
  • Prof. Dr. Randy Schekman,
    Department of Molecular and Cell Biology, University of California, Berkeley, USA
  • Prof. Dr. Amita Sehgal,
    Howard Hughes Medical Institute, University of Pennsylvania, Philadelphia, USA
  • Prof. Dr. Antonio Simeone,
    Institute of Genetics and Biophysics "Adriano Buzzati Traverso", Napoli, Italy
  • Prof. Dr. Peter So,
    Massachusetts Institute of Technology, Dept. of Mechanical Engineering, Cambridge, USA
  • Prof. Dr. David Tollervey,
    Wellcome Trust Centre for Cell Biology, University of Edinburgh, Edinburgh, UK

Go to Editor View